Friday - March 20, 2026

Category Archives: Pharmaceuticals & Biotech

Industrial Applications of 5-Hydroxymethylfurfural (5-HMF, CAS 67-47-0): Insights from a Chemical Supplier

As global industries shift toward renewable raw materials and sustainable chemistry, 5-Hydroxymethylfurfural (5-HMF, CAS 67-47-0) has gained increasing attention as an important bio-based platform chemical. Derived from carbohydrates such as fructose and glucose, 5-HMF provides a bridge between biomass resources … Continue reading →

Cystic Fibrosis Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Insmed, AstraZeneca, Zambion, The Marcus Foundation, Chiesi Farmaceutici, SolAeroMed

The Key Cystic Fibrosis Companies in the market include – Vertex Pharmaceuticals, Verona Pharmaceuticals, Boehringer Ingelheim, Zambon, Insmed, AstraZeneca, Zambion, The Marcus Foundation, Inc., Chiesi Farmaceutici S.p.A., SolAeroMed Inc., Zambon SpA, Boehringer Ingelheim, Renovion, Inc., Novartis, Alaxia SAS, and others. … Continue reading →

Asthma Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Lanier Biotherapeutics, Bio-Thera Solutions, Kinaset Therapeutics, CSPC ZhongQi Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Asthma pipeline constitutes 80+ key companies continuously working towards developing 90+ Asthma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading →

Projecting the Global Neuromodulation Devices Market Size to Expand at a 9.44% CAGR Through 2032, DelveInsight Analysis

Neuromodulation Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The neuromodulation devices market is experiencing rapid growth, … Continue reading →

Amyotrophic Lateral Sclerosis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharmaceuticals

The Key Amyotrophic Lateral Sclerosis Companies in the market include – Amylyx Pharmaceuticals, Sanofi, Brainstorm Cell Therapeutics, AI Therapeutics, Ionis, Biogen, Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, Alector, GSK, NeuroSense Therapeutics, Biogen, Ionis Pharmaceuticals, Brainstorm Cell Therapeutics, Cytokinetics, Astellas Pharma, … Continue reading →

Projecting the Global Neurothrombectomy Devices Market Size to Expand at a 6.88% CAGR Through 2032, DelveInsight Analysis

Neurothrombectomy Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The neurothrombectomy devices market is largely driven by … Continue reading →

Atopic Dermatitis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | GlaxoSmithKline PLC, Nestle SA, Pfizer Inc., Regeneron Pharma, Abbvie

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 120+ Atopic Dermatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Complement 3 Glomerulopathy Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | NovelMed Therapeutics, Apellis Pharma, Novartis, Amyndas Pharma

The Key Complement 3 Glomerulopathy Companies in the market include – NovelMed Therapeutics, Apellis Pharmaceuticals, Novartis, Amyndas Pharmaceuticals, and others.   DelveInsight’s “Complement 3 Glomerulopathy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Complement 3 … Continue reading →